News
Drug companies defend rewards to doctors for switching treatments
BMJ 2003; 326 doi: https://doi.org/10.1136/bmj.326.7380.67/a (Published 11 January 2003) Cite this as: BMJ 2003;326:67
- Charles Marwick
- Washington, DC
Pharmaceutical companies in the United States have criticised attempts by the government to restrict handouts and promotions to doctors.
Department of Health and Human Services guidelines issued last October warn drug manufacturers against payments or other encouragement, such as entertainment and travel, to doctors and health professionals to switch patients to their own products (BMJ 2002;325:795).
The government is …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.